Thomas Leeuw

Frankfurt Am Main, HE 65926, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Microphysiological System-Generated Physiological Shear Forces Reduce TNF-α-Mediated Cartilage Damage in a 3D Model of Arthritis.

Microphysiological System-Generated Physiological Shear Forces Reduce TNF-α-Mediated Cartilage Damage in a 3D Model of Arthritis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 27, 2024

Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.

Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.

Journal: Frontiers in pharmacology

Published: August 12, 2024

Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa.

Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa.

Journal: The journal of allergy and clinical immunology. Global

Published: June 13, 2024

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug.

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug.

Journal: Osteoarthritis and cartilage

Published: November 17, 2022

Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets.

Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets.

Journal: Cell reports

Published: October 25, 2022

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.

Journal: Frontiers in pharmacology

Published: September 06, 2022

Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.

Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.

Journal: The Journal of allergy and clinical immunology

Published: March 25, 2022

Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.

Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.

Journal: The British journal of dermatology

Published: December 30, 2020

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.

Journal: Disease models & mechanisms

Published: August 05, 2020

Complex human adenoid tissue-based ex vivo culture systems reveal anti-inflammatory drug effects on germinal center T and B cells.

Complex human adenoid tissue-based ex vivo culture systems reveal anti-inflammatory drug effects on germinal center T and B cells.

Journal: EBioMedicine

Published: October 18, 2019

High throughput screening of mitochondrial bioenergetics in human differentiated myotubes identifies novel enhancers of muscle performance in aged mice.

High throughput screening of mitochondrial bioenergetics in human differentiated myotubes identifies novel enhancers of muscle performance in aged mice.

Journal: Scientific reports

Published: July 11, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026